Asthma Insurance Claim Denied in Pennsylvania? Here's Your Appeal Roadmap

Pennsylvania residents with severe asthma and COPD are frequently caught in insurance step therapy loops that delay or deny access to FDA-approved biologics. Whether you're on a commercial plan, CHIP, or Medicaid, Pennsylvania law gives you meaningful rights to appeal. Here's how to navigate them.

Why Pennsylvania Insurers Deny Asthma Claims

Denials in Pennsylvania commonly take these forms:

• Step therapy for biologics: Insurers require failure on inhaled corticosteroids, LABAs, and sometimes multiple oral corticosteroid courses before approving Dupixent, Fasenra, or Nucala
• Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization denials for Dupixent: Insurers dispute whether patients meet eosinophil thresholds even when FDA labeling supports broader use
• Nebulizer and DME denials: Home nebulizers denied as "not medically necessary" or "duplicative" with inhalers
• Rescue inhaler quantity limits: Albuterol and levalbuterol fills restricted even for patients with frequent exacerbations requiring multiple uses daily
• Out-of-network specialist denials: Rural Pennsylvania patients often lack in-network allergists or pulmonologists

Pennsylvania Insurance Regulator: PID

The Pennsylvania Insurance Department (PID) oversees commercial health insurers and handles External Independent Review: Complete Guide" class="auto-link">external review requests in Pennsylvania.

PID Consumer Services:

• Phone: 1-877-881-6388
• Website: insurance.pa.gov
• File a complaint: insurance.pa.gov/Consumers/pages/FileaComplaint.aspx

For HMO grievances, the Pennsylvania Department of Health also has oversight authority. Pennsylvania's external review law requires independent review of adverse benefit determinations, with binding decisions for medical necessity disputes.

Pennsylvania's Step Therapy Protections

Pennsylvania's Act 44 of 2021 (step therapy reform) requires health insurers to grant exceptions to step therapy protocols when:

• The required treatment is contraindicated
• The patient previously tried and failed the treatment
• The required treatment would cause adverse effects based on the patient's documented clinical history
• The patient's current stabilization on a non-preferred medication warrants continuity

Submit your step therapy exception request with full clinical documentation from your prescribing physician. PID requires insurers to respond within 72 hours for standard requests and 24 hours for urgent clinical situations.

CHIP and Pediatric Asthma in Pennsylvania

Pennsylvania's Children's Health Insurance Program (CHIP) covers children in families that earn too much for Medicaid but cannot afford private insurance. CHIP covers asthma medications including inhaled corticosteroids, LABAs, leukotriene modifiers, and in appropriate cases, biologics.

For CHIP biologic denials:

• Appeal with the CHIP managed care plan within 30 days
• Request a State Fair Hearing through DHS: 1-800-692-7462
• Contact Pennsylvania Health Law Project: phlp.org for free legal help

Biologics for Severe Asthma: The Pennsylvania Appeal Case

For biologic denial appeals, your physician must document all of the following:

• Dupixent (dupilumab): Approved for moderate-to-severe eosinophilic asthma AND for OCS-dependent asthma regardless of eosinophil count. This is a critical point — many Pennsylvania insurers incorrectly limit Dupixent to patients with high eosinophil counts alone
• Fasenra (benralizumab): Severe eosinophilic asthma, eosinophils ≥300 cells/μL
• Nucala (mepolizumab): Severe eosinophilic asthma; also now FDA-approved for COPD with eosinophilic phenotype — highly relevant for Pennsylvania's industrial and coal-country COPD patients
• Tezspire (tezepelumab): Uncontrolled severe asthma without minimum eosinophil requirement — your strongest argument for mixed-phenotype asthma
• Xolair (omalizumab): Moderate-to-severe allergic asthma

Your appeal letter should cite the FDA prescribing information directly and demonstrate that the insurer's internal criteria are more restrictive than FDA labeling — a key ground for appeal under both state law and federal ERISA regulations.

Pennsylvania Medicaid and Asthma

Pennsylvania Medicaid (Medical Assistance / MA) is administered through HealthChoices MCOs including Highmark Wholecare, UPMC for You, AmeriHealth Caritas PA, and Geisinger Health Plan. Biologic coverage requires prior authorization.

For MA denials:

• File an internal grievance with your MCO within 30 days
• Request a State Fair Hearing: 1-800-692-7462
• Contact Community Legal Services in Philadelphia: clsphila.org
• Contact MidPenn Legal Services for central PA: midpennlegal.org

Pennsylvania's Industrial Asthma and COPD Burden

Pennsylvania's history of coal mining, steel production, and coke manufacturing has left lasting respiratory health consequences in communities across the Mon Valley, Altoona, Scranton, and the anthracite coal region. COPD and asthma rates are disproportionately high in these areas. Nucala's new COPD indication is particularly relevant for Pennsylvania patients with occupational or environmental respiratory disease.

Step-by-Step Appeal Process in Pennsylvania

1. Get denial in writing: Demand a written denial with specific clinical criteria used
2. File internal appeal: Submit within 30–180 days; include physician's letter of medical necessity, lab values, and exacerbation history
3. Peer-to-peer review: Your doctor contacts insurer's medical director — document this call
4. Step therapy exception request: Cite Pennsylvania Act 44 of 2021
5. External review through PID: After adverse internal appeal decision
6. PID complaint: insurance.pa.gov — creates regulatory record and investigation

Pennsylvania Advocacy Resources

• American Lung Association – Pennsylvania: lung.org | 1-800-586-4872
• Pennsylvania Health Law Project: phlp.org — free healthcare legal assistance
• Health Law PA: healthlawpa.org — insurance appeal resources
• NAACP Pennsylvania State Conference: naacppa.org — health equity advocacy in environmental justice communities

Fight Back With ClaimBack

Pennsylvania's biologic patients deserve the full benefits of modern medicine. ClaimBack builds appeal letters that cite Pennsylvania's step therapy laws, FDA approval standards, and the specific clinical evidence insurers cannot legally ignore.

Start your appeal at ClaimBack — built specifically for patients like you.

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs. External Insurance Appeal: Which Should You File?